Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Aymeric Sallin
AddedMar 31, 2024
UpdatedMay 31, 2026
Aymeric Sallin

Aymeric Sallin

Board Member, Selecta Biosciences

CrunchbaseLinkedIn

Aymeric Sallin's Career

Selecta Biosciences
Selecta Biosciences

Watertown, MA, US

Board Member· Board
+ND Capital
+ND Capital

San Mateo, CA, US

Founder & CEO· C-Suite · Management
View
View

Milpitas, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Aymeric Sallin's Career

Selecta Biosciences
Selecta Biosciences
Public$380.5M752008Watertown, MA, US
Board Member· Board

Leadership at Selecta Biosciences

George SiberGeorge SiberBoard Member
Omid FarokhzadOmid FarokhzadFounder

Similar to Selecta Biosciences

Cleveland BioLabsCleveland BioLabsFort Collins, CO, USImmunotherapiesest. 2003Cleveland BioLabsFort Collins, CO, US · est. 2003

Biotech research agency restoring immune health through safe drugs.

Public · $112.2M75
ImunonImunonLawrenceville, NJ, USBiotech, Treatmentsest. 2000ImunonLawrenceville, NJ, US · est. 2000

IMUNON, Inc., a US-based clinical stage biotech company, innovates safe and effective treatments for a broad array of diseases.

Public · $113.8M27
NantkwestNantkwestCulver City, CA, USCancer Treatment, Immunotherapyest. 2014NantkwestCulver City, CA, US · est. 2014

ImmunityBio, Inc.: A US-based biotech firm specializing in immunotherapy for cancer and infectious diseases.

Public · $103.5M51
MacroGenicsMacroGenicsRockville, MD, USest. 2000MacroGenicsRockville, MD, US · est. 2000

US-based MacroGenics, Inc. develops novel biologics for cancer, autoimmune disorders, and infectious diseases.

Public · $165.9M357
+ND Capital
+ND Capital
Investment Firm202002San Mateo, CA, US
Founder & CEO· C-Suite · Management

Similar to +ND Capital

NdcapitalNdcapitalLos Angeles, CA, USest. 2017NdcapitalLos Angeles, CA, US · est. 2017

NDCapital: An alternative venture fund for early-growth, tech-enabled services companies.

5
Northpond VenturesNorthpond VenturesBethesda, MD, USest. 2018Northpond VenturesBethesda, MD, US · est. 2018

Northpond Ventures LLC: A US-based private equity firm specializing in life sciences and technology investments.

55
Nth PowerNth PowerSan Francisco, CA, USest. 1997Nth PowerSan Francisco, CA, US · est. 1997

Nth Power: Leading SF venture capital firm funding energy tech startups, with $420M under management since 1997.

8
NuFund Venture GroupNuFund Venture GroupSan Diego, CA, USest. 1997NuFund Venture GroupSan Diego, CA, US · est. 1997

NuFund Venture Group: A modern investment group for tech startup angel investing.

118
View
View
Public$2.6B6312007Milpitas, CA, US
Board Member· Board

Leadership at View

Jeffrey EvensonJeffrey EvensonBoard Member
Tom PattersonTom PattersonBoard Member
Samir KaulSamir KaulBoard Member
Weston QuashaWeston QuashaBoard Member
Fahri DinerFahri DinerBoard Member
Gary DillaboughGary DillaboughBoard Member

Similar to View

iGlass TechnologyiGlass TechnologyIrvine, CA, USSmart Windowsest. 2014iGlass TechnologyIrvine, CA, US · est. 2014

iGlass Technology: Innovating Smart Windows with digitally tunable light transmittance.

Seed · $6.2M31
HalioHalioHayward, CA, USSmart Glassest. 2010HalioHayward, CA, US · est. 2010

Transforming architecture with advanced smart-tinting glass, Halio offers efficient, comfortable, and inspiring spaces through innovative technology.

Series D · $399M375
Bright View TechnologiesBright View TechnologiesDurham, NC, USLightingest. 2002Bright View TechnologiesDurham, NC, US · est. 2002

Bright View: Innovating in optical film technology and engineered optics as a leading lighting manufacturer.

Series C · $26.5M46
Tynt TechnologiesTynt TechnologiesBoulder, CO, USSmart Windowsest. 2020Tynt TechnologiesBoulder, CO, US · est. 2020

Tynt Technologies develops smart windows for glare prevention, energy saving, and view maintenance.

Seed · $17.1M35

People Similar to Aymeric Sallin

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakHaeil YiHaeil YiCo-Founder · DunamuLee Sirg-OoLee Sirg-OoCEO · DunamuYoav SternYoav SternBoard Member · Nano DimensionDavid PeraltaDavid PeraltaBoard Member · WpmcDavid A WoodleDavid A WoodleBoard Member · ArrisBryce KnightBryce KnightCo-Founder · Revenue.comAndrey SmolyaninovAndrey SmolyaninovCo-Founder · Nano Meta TechnologiesRon WohlRon WohlCEO · Nanoscale Components